潤達醫療(603108.SH)快速拉昇一度觸及漲停 提供新冠病毒檢測試劑及相關檢測儀器設備
格隆匯2月3日丨潤達醫療(603108.SH)出現幾波快速拉昇走勢,一度觸及漲停,現報11.19元,漲5.57%,暫成交2.28億元,最新總市值65億元。

公司今日在互動平台表示,在此次新冠病毒肺炎疫情中,公司為各級醫院客户提供了包括新冠病毒檢測試劑等各類檢測試劑盒及相關檢測儀器設備。同時公司也負責雷神山醫院所有的檢測試劑及耗材的供應。目前,與疫情檢測相關的血球儀、PCR儀、發光儀等檢測設備需求較大。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.